Transapical transcatheter aortic valve implantation: follow-up to 3 years.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 20412948)

Published in J Thorac Cardiovasc Surg on May 01, 2010

Authors

Jian Ye1, Anson Cheung, Samuel V Lichtenstein, Fabian Nietlispach, Saad Albugami, Jean-Bernard Masson, Christopher R Thompson, Brad Munt, Robert Moss, Ronald G Carere, W R Eric Jamieson, John G Webb

Author Affiliations

1: Division of Cardiac Surgery, St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. jye@providencehealth.bc.ca

Articles citing this

Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol (2010) 1.23

Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Imaging (2015) 1.14

Transcatheter aortic valve implantation: Current status and future perspectives. World J Cardiol (2011) 1.06

Patient-specific modeling of biomechanical interaction in transcatheter aortic valve deployment. J Biomech (2012) 0.92

Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med (2014) 0.87

A systematic review of transapical aortic valve implantation. Ann Cardiothorac Surg (2012) 0.84

Transapical aortic valve implantation: The Vancouver experience. Ann Cardiothorac Surg (2012) 0.81

Optimal timing of aortic valve replacement in elderly patients with severe aortic stenosis. Surg Today (2013) 0.80

Clinical trial experience with transcatheter aortic valve insertion. Int J Cardiovasc Imaging (2011) 0.80

Early and intermediate survival after transcatheter aortic valve implantation: systematic review and meta-analysis of 14 studies. BMJ Open (2013) 0.79

MDCT evaluation of aortic root and aortic valve prior to TAVI. What is the optimal imaging time point in the cardiac cycle? Eur Radiol (2015) 0.77

Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2015) 0.77

Quantification of biomechanical interaction of transcatheter aortic valve stent deployed in porcine and ovine hearts. Ann Biomed Eng (2012) 0.77

Aortic valve replacement vs. transcatheter aortic valve implantation: Patient selection. Ann Cardiothorac Surg (2012) 0.76

Practical update on imaging and transcatheter aortic valve implantation. World J Cardiol (2015) 0.75

The first successful transapical aortic valve implant in Korea. J Korean Med Sci (2011) 0.75

Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged ≥ 75 years: the effects of EuroSCORE and patient operability. J Geriatr Cardiol (2015) 0.75

Fatigue damage of collagenous tissues: experiment, modeling and simulation studies. J Long Term Eff Med Implants (2015) 0.75

Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches. J Interv Card Electrophysiol (2016) 0.75

[Transcatheter aortic valve replacement: when should it be used in aortic stenosis?]. Wien Med Wochenschr (2012) 0.75

Dynamics of the aortic annulus in 4D CT angiography for transcatheter aortic valve implantation patients. PLoS One (2017) 0.75

Articles by these authors

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation (2006) 3.94

Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation (2010) 3.65

Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation (2007) 3.44

The genomics education partnership: successful integration of research into laboratory classes at a diverse group of undergraduate institutions. CBE Life Sci Educ (2010) 3.42

Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78

Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv (2013) 2.75

Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg (2006) 2.61

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA (2006) 2.35

Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv (2006) 2.34

Prosthesis size and long-term survival after aortic valve replacement. J Thorac Cardiovasc Surg (2003) 2.22

True versus reported waiting times for valvular aortic stenosis surgery. Can J Cardiol (2006) 2.21

Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes. JACC Cardiovasc Interv (2013) 2.20

Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol (2007) 2.11

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11

Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09

Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv (2011) 2.06

Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol (2009) 2.05

Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02

Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation (2006) 2.02

Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation (2009) 2.00

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99

Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv (2011) 1.98

Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv (2008) 1.98

Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg (2006) 1.91

Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging (2008) 1.91

Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv (2011) 1.88

Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging (2008) 1.82

Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81

Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol (2004) 1.77

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72

Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). Eur J Cardiothorac Surg (2005) 1.68

Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation (2012) 1.66

Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention. Am Heart J (2010) 1.65

Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. JACC Cardiovasc Interv (2008) 1.63

Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61

An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv (2010) 1.60

Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis. Ann Thorac Surg (2010) 1.57

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. J Thorac Cardiovasc Surg (2010) 1.56

Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J (2005) 1.56

Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial. Catheter Cardiovasc Interv (2009) 1.54

Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv (2009) 1.53

Treating the right patient at the right time: access to specialist consultation and non-invasive testing. Can J Cardiol (2006) 1.52

Stenting for coronary artery spasm. Catheter Cardiovasc Interv (2002) 1.50